Sharon Roberg-Perez

Sharon Roberg-Perez

Robins Kaplan LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

The Future is Now

More than a decade ago Steve Spielberg’s Minority Report contemplated a future in which facial recognition would be ubiquitously used for targeted advertising. Now, a California court will decide whether to dismiss a...more

11/18/2016 - Article III Biometric Information Biometric Information Privacy Act Data Collection Facebook Facial Recognition Technology Injury-in-Fact Motion to Dismiss Privacy Laws Social Media Software Spokeo v Robins Standing Technology Sector

Genomics and FDA Regulation: A Work in Progress

It took over a decade to sequence the human genome the first time, at a cost between half a billion and a billion dollars. Now, however? An entire human genome can be sequenced for one or two thousand dollars, in a matter of...more

10/27/2016 - Complete Genomics FDA Genetic Testing Healthcare Innovation

The Tech Industry’s Next Frontier?

Tongue-in-cheek references to Pokémon Go as a health App aside, maybe the tech industry is on to something. In the U.S., seven out of every ten deaths are due to chronic diseases, such as diabetes or heart disease. Perhaps...more

10/17/2016 - Best Practices FDA FTC GINA Healthcare HIPAA Medical Devices Mobile Apps PHI Pokemon Popular Privacy Concerns Security Standards Smartphones Technology Technology Sector Third-Party Service Provider Wellness Programs

[Webinar] Best Practices for Licensing in Today's Evolving Legal Framework - June 16th, 1:00pm CST

The Supreme Court of the United States recently held that royalty payments beyond the expiration of a patent are per se unlawful. However, many ground-breaking technologies being developed and licensed from the nation's...more

6/1/2016 - Educational Institutions Kimble v Marvel Enterprises License Agreements Patent Expiration Patent Royalties Patents Royalties Webinars

[Webinar] Recent Legal & Economic Developments That Affect Your Biotech Business - March 29th, 2:00pm EST

The greatest asset of a young biotech company is its intellectual property. Strategic decisions made during the initial organization and early growth of your company have a lasting impact on its success. In this webinar, we...more

3/24/2016 - Biosimilars Biotechnology Intellectual Property Protection Patent-Eligible Subject Matter Patents Pharmaceutical Industry Pharmaceutical Patents Webinars

[Webinar] The Digital Health Update: Recent Developments in the Regulation of Medical Devices and Health Apps - Sept. 22nd, 1:00...

Tuesday, September 22, 2015, 1:00 P.M. CST -- Both the FDA and the FTC have been busy this summer. Just this month, both agencies took their strongest actions to date relating to cybersecurity and the regulation of medical...more

9/11/2015 - Cybersecurity Digital Health FDA FTC mHealth Mobile Health Apps Popular Webinars

How to Keep What is Yours: Practical Considerations for Healthcare IT Protection

One of the worst kept secrets is the experienced and expected growth in healthcare IT. In 2013, over $650 million was invested into healthcare IT companies, and the trend is continuing to grow. Combined with the fact that...more

6/11/2015 - Apple CLS Bank v Alice Corp Confidentiality Agreements Copyright Google Health Information Technologies Healthcare Information Technology Patents SCOTUS Software Technology Trade Secrets

PATIENT PRIVACY IN AN ERA OF SOCIAL MEDIA [Video]

The rise of social media has introduced new opportunities and new legal challenges for companies in the health care industry. Attorneys Seth Northrop and Sharon Roberg-Perez discuss the legal issues faced by care providers,...more

4/9/2015 - Best Management Practices Data Mining FDA Health Care Providers Healthcare HIPAA Hospitals Labeling Medical Devices Patients Pharmaceutical Industry Privacy Laws Risk Management Social Media Terms of Use User-Generated Content

Make Sure You Own the Patent You Think You Do.

The biotechnology industry has a long history of successfully licensing and litigating university technology. That trend looks to be continuing, even as other industries have taken aim at limiting patent enforcement. Ten U.S....more

12/17/2014 - Assignment of Inventions Assignments Biotechnology Inventors IP Assignment Agreements Licenses Patents Universities

A Cautionary Tale for Universities about Patent Ownership Rights from the Lone Star State

A recent decline in patent litigation has been attributed to the evolving patent eligibility standard, as well as to an increase in post-grant review proceedings at the Patent Office, now reported to be “the second-biggest...more

11/14/2014 - License Agreements Patent Infringement Patent Litigation Patent-Eligible Subject Matter Patents Post-Grant Review Universities

FDA Issues Draft Guidance for Laboratory Developed Tests

For almost 40 years the FDA has regulated in vitro diagnostics (IVDs) as medical devices. An IVD is a reagent, instrument, or system that is intended for the diagnosis of a disease or other condition, including the...more

10/2/2014 - Clinical Laboratories FDA Laboratory Developed Tests Medical Devices

Clones Not Patent-Eligible?

Thanks to recent advances in cloning technology, treating degenerative diseases with replacement tissue that matches a patient’s genetic makeup exactly is no longer science fiction. Just last month, for example, two research...more

5/9/2014 - DNA Medical Research Myriad Patent Trial and Appeal Board Patent-Eligible Subject Matter Patents Stem cells USPTO

Personalized Medicine and Patent Eligibility under 35 U.S.C. § 101

Double-digit growth is predicted for the molecular diagnostic market in the next several years, driven in part by an increased demand for personalized medicine—medical decisions and therapeutic products tailored to address...more

4/25/2014 - Bristol-Myers Squibb Diagnostic Tests FDA Genetic Technologies Ltd. Healthcare Infringement Patent Litigation Patents Sequenom

13 Results
|
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×